These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 4721904)

  • 1. [Examinations on respiratory mechanisms in cases with progressive systemic sclerosis].
    Hutás I; Urai L; Böszörményi-Nagy G; Grosz A
    Respiration; 1973; 30(2):141-52. PubMed ID: 4721904
    [No Abstract]   [Full Text] [Related]  

  • 2. Serial changes in scleroderma and idiopathic interstitial lung disease.
    Colp CR; Riker J; Williams MH
    Arch Intern Med; 1973 Oct; 132(4):506-15. PubMed ID: 4742404
    [No Abstract]   [Full Text] [Related]  

  • 3. [Lung function disturbances in fibrosis].
    Arzt GH
    Internist (Berl); 1974 Jul; 15(7):364-9. PubMed ID: 4608156
    [No Abstract]   [Full Text] [Related]  

  • 4. Static lung compliance as an index of early pulmonary disease in systemic sclerosis.
    Sud A; Gupta D; Wanchu A; Jindal SK; Bambery P
    Clin Rheumatol; 2001; 20(3):177-80. PubMed ID: 11434468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Esophageal motility and pulmonary function in progressive systemic sclerosis.
    Denis P; Ducrotte P; Pasquis P; Lefrançois R
    Respiration; 1981; 42(1):21-4. PubMed ID: 7330460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary manifestations of progressive systemic sclerosis.
    DeMuth GR; Furstenberg NA; Dabich L; Zarafonetis CJ
    Am J Med Sci; 1968 Feb; 255():94-104. PubMed ID: 5639554
    [No Abstract]   [Full Text] [Related]  

  • 7. Inspiratory crackles and mechanical events of breathing.
    Nath AR; Capel LH
    Thorax; 1974 Nov; 29(6):695-8. PubMed ID: 4450179
    [No Abstract]   [Full Text] [Related]  

  • 8. Association of gastroesophageal factors and worsening of forced vital capacity in systemic sclerosis.
    Zhang XJ; Bonner A; Hudson M; ; Baron M; Pope J
    J Rheumatol; 2013 Jun; 40(6):850-8. PubMed ID: 23547215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung function in progressive systemic sclerosis is dominated by poorly compliant lungs and stiff airways.
    Blom-Bülow B; Jonson B; Brauer K
    Eur J Respir Dis; 1985 Jan; 66(1):1-8. PubMed ID: 3979473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Respiratory function in systemic lupus erythematosus, scleroderma, and rheumatoid arthritis.
    Laitinen O; Salorinne V; Poppius H
    Ann Rheum Dis; 1973 Nov; 32(6):531-5. PubMed ID: 4760476
    [No Abstract]   [Full Text] [Related]  

  • 11. [On the importance of measurement of compliance in pneumology].
    Wiesendanger T; Brune J; Galy P
    Lyon Med; 1968 Mar; 219(13):1091-124. PubMed ID: 5745992
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pulmonary changes in progressive systemic sclerosis].
    Yao WZ
    Zhonghua Jie He He Hu Xi Za Zhi; 1990 Jun; 13(3):157-9, 191. PubMed ID: 2249319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of serial high-resolution computed tomography analyses and concurrent lung function tests in systemic sclerosis.
    Hoffmann-Vold AM; Aaløkken TM; Lund MB; Garen T; Midtvedt Ø; Brunborg C; Gran JT; Molberg Ø
    Arthritis Rheumatol; 2015 May; 67(8):2205-12. PubMed ID: 25916462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Respiratory functions in pulmonary fibrosis].
    Honma Y
    Kokyu To Junkan; 1978 Jan; 26(1):35-44. PubMed ID: 628801
    [No Abstract]   [Full Text] [Related]  

  • 15. [Studies of respiratory mechanics in pulmonary sarcoidosis].
    Doll E; Kröpelin K
    Pneumonologie; 1972; 148(1):7-23. PubMed ID: 4640030
    [No Abstract]   [Full Text] [Related]  

  • 16. Retrospective studies in scleroderma: pulmonary findings and effect of potassium p-aminobenzoate on vital capacity.
    Zarafonetis CJ; Dabich L; Devol EB; Skovronski JJ; Negri D; Yuan WY
    Respiration; 1989; 56(1-2):22-33. PubMed ID: 2602668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Level of Chemokine CCL18 Is Associated With Pulmonary Function Deterioration, Lung Fibrosis Progression, and Reduced Survival in Systemic Sclerosis.
    Hoffmann-Vold AM; Tennøe AH; Garen T; Midtvedt Ø; Abraityte A; Aaløkken TM; Lund MB; Brunborg C; Aukrust P; Ueland T; Molberg Ø
    Chest; 2016 Aug; 150(2):299-306. PubMed ID: 26997242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiopulmonary manifestations of progressive systemic sclerosis: associations with circulating immune complexes and fluorescent antinuclear antibodies.
    Pisko E; Gallup K; Turner R; Parker M; Nomeir AM; Box J; Davis J; Box P; Rothberger H
    Arthritis Rheum; 1979 May; 22(5):518-23. PubMed ID: 375941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary arterial hypertension and severe pulmonary fibrosis in systemic sclerosis patients with a nucleolar antibody.
    Steen VD; Lucas M; Fertig N; Medsger TA
    J Rheumatol; 2007 Nov; 34(11):2230-5. PubMed ID: 17937469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Importance in examination of the lung mechanics and volume in idiopathic interstitial pulmonary fibrosis].
    Zapletal A; Paul T; Samánek M; Copová M; Suková V
    Cesk Pediatr; 1974 Jul; 29(7):375-81. PubMed ID: 4409791
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.